Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Di Stefano

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Anti-Cancer Drugs|June 26, 2013
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1Marina Vettraino, Marcella Manerba, Marzia Govoni, et al.
Biochimica Et Biophysica Acta. General Subjects|June 6, 2022
Lactate is a potential promoter of tamoxifen resistance in MCF7 cellsValentina Rossi, Marzia Govoni, Fulvia Farabegoli, et al.
Aging and Disease|February 16, 2017
Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Focus on Mitochondrial DNA and Alzheimer's DiseaseAnnamaria Zaia, Pierluigi Maponi, Giuseppina Di Stefano, et al.
Future Medicinal Chemistry|April 8, 2016
Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatmentGiuseppina Di Stefano, Marcella Manerba, Lorenza Di Ianni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Liver-targeted doxorubicin: effects on rat regenerating hepatocytesGiuseppina Di Stefano, Massimo Derenzini, Felix Kratz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 30, 2004
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugateGiuseppina Di Stefano, Marcella Lanza, Felix Kratz, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: requirements for a regional chemotherapyGiuseppina Di Stefano, Marcella Lanza, Corrado Busi, et al.
Drug Discovery Today|August 30, 2008
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drugLuigi Fiume, Michele Baglioni, Luigi Bolondi, et al.
Bioscience Reports|January 20, 2022
Human lactate dehydrogenase A undergoes allosteric transitions under pH conditions inducing the dissociation of the tetrameric enzymeAlberto Pietro Pasti, Valentina Rossi, Giuseppina Di Stefano, et al.
Plos One|August 24, 2018
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cellsMarcella Manerba, Lorenza Di Ianni, Marzia Govoni, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|June 26, 2013
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1Marina Vettraino, Marcella Manerba, Marzia Govoni, et al.
Biochimica Et Biophysica Acta. General Subjects|June 6, 2022
Lactate is a potential promoter of tamoxifen resistance in MCF7 cellsValentina Rossi, Marzia Govoni, Fulvia Farabegoli, et al.
Aging and Disease|February 16, 2017
Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Focus on Mitochondrial DNA and Alzheimer's DiseaseAnnamaria Zaia, Pierluigi Maponi, Giuseppina Di Stefano, et al.
Future Medicinal Chemistry|April 8, 2016
Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatmentGiuseppina Di Stefano, Marcella Manerba, Lorenza Di Ianni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Liver-targeted doxorubicin: effects on rat regenerating hepatocytesGiuseppina Di Stefano, Massimo Derenzini, Felix Kratz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 30, 2004
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugateGiuseppina Di Stefano, Marcella Lanza, Felix Kratz, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: requirements for a regional chemotherapyGiuseppina Di Stefano, Marcella Lanza, Corrado Busi, et al.
Drug Discovery Today|August 30, 2008
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drugLuigi Fiume, Michele Baglioni, Luigi Bolondi, et al.
Bioscience Reports|January 20, 2022
Human lactate dehydrogenase A undergoes allosteric transitions under pH conditions inducing the dissociation of the tetrameric enzymeAlberto Pietro Pasti, Valentina Rossi, Giuseppina Di Stefano, et al.
Plos One|August 24, 2018
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cellsMarcella Manerba, Lorenza Di Ianni, Marzia Govoni, et al.
Pageof 9